Huw Nash
Chief Operating Officer bei STOKE THERAPEUTICS, INC.
Profil
Dr. Huw M.
Nash is a Chief Operating & Business Officer at Stoke Therapeutics, Inc. Dr. Nash was previously employed as a Vice President-Corporate Development by Aileron Therapeutics, Inc. and a VP-External Collaborations & Founding Scientist by NeoGenesis Pharmaceuticals, Inc. He received his undergraduate degree from Harvard College and a doctorate degree from Harvard University.
Aktive Positionen von Huw Nash
| Unternehmen | Position | Beginn |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Chief Operating Officer | 01.10.2017 |
Ehemalige bekannte Positionen von Huw Nash
| Unternehmen | Position | Ende |
|---|---|---|
| AILERON THERAPEUTICS, INC. | Founder | 01.01.2013 |
NeoGenesis Pharmaceuticals, Inc.
 NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Corporate Officer/Principal | 01.01.2005 |
Ausbildung von Huw Nash
| Harvard University | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AILERON THERAPEUTICS, INC. | Health Technology |
| STOKE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
NeoGenesis Pharmaceuticals, Inc.
NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Health Technology |
